Abrdn Life Sciences Investors (HQL) Competitors $14.29 +0.08 (+0.56%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HQL vs. CET, MFIC, NMFC, BCSF, BBDC, HQH, CGBD, BTO, PHK, and ECCShould you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include Central Securities (CET), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), Bain Capital Specialty Finance (BCSF), Barings BDC (BBDC), Abrdn Healthcare Investors (HQH), Carlyle Secured Lending (CGBD), John Hancock Financial Opportunities Fund (BTO), PIMCO High Income Fund (PHK), and Eagle Point Credit (ECC). These companies are all part of the "financial services" industry. Abrdn Life Sciences Investors vs. Central Securities MidCap Financial Investment New Mountain Finance Bain Capital Specialty Finance Barings BDC Abrdn Healthcare Investors Carlyle Secured Lending John Hancock Financial Opportunities Fund PIMCO High Income Fund Eagle Point Credit Central Securities (NYSE:CET) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, community ranking, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations. Does the MarketBeat Community favor CET or HQL? Abrdn Life Sciences Investors received 95 more outperform votes than Central Securities when rated by MarketBeat users. CompanyUnderperformOutperformCentral SecuritiesN/AN/AAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% Does the media favor CET or HQL? In the previous week, Central Securities had 3 more articles in the media than Abrdn Life Sciences Investors. MarketBeat recorded 3 mentions for Central Securities and 0 mentions for Abrdn Life Sciences Investors. Abrdn Life Sciences Investors' average media sentiment score of 2.00 beat Central Securities' score of 1.74 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the news media. Company Overall Sentiment Central Securities Very Positive Abrdn Life Sciences Investors Very Positive Which has stronger valuation & earnings, CET or HQL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentral SecuritiesN/AN/AN/AN/AN/AAbrdn Life Sciences InvestorsN/AN/AN/AN/AN/A Which has more volatility and risk, CET or HQL? Central Securities has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Is CET or HQL a better dividend stock? Central Securities pays an annual dividend of $2.25 per share and has a dividend yield of 4.9%. Abrdn Life Sciences Investors pays an annual dividend of $1.66 per share and has a dividend yield of 11.6%. Is CET or HQL more profitable? Company Net Margins Return on Equity Return on Assets Central SecuritiesN/A N/A N/A Abrdn Life Sciences Investors N/A N/A N/A Do insiders & institutionals have more ownership in CET or HQL? 8.7% of Central Securities shares are owned by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. 10.3% of Central Securities shares are owned by insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryAbrdn Life Sciences Investors beats Central Securities on 4 of the 7 factors compared between the two stocks. Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricAbrdn Life Sciences InvestorsInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$388.65M$8.31B$10.41B$19.84BDividend Yield11.68%6.40%10.14%3.50%P/E RatioN/A0.4647.1237.73Price / SalesN/A24.163,443.7818.01Price / CashN/A6.9930.7717.90Price / BookN/A0.912.484.86Net IncomeN/A$73.96M$993.44M$985.93M7 Day Performance-0.90%-0.51%-0.05%0.45%1 Month Performance-5.55%-1.92%7.13%1.05%1 Year Performance22.03%11.36%24.11%24.67% Abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLAbrdn Life Sciences InvestorsN/A$14.29+0.6%N/A+17.4%$388.65MN/A0.00N/APositive NewsHigh Trading VolumeCETCentral SecuritiesN/A$46.26-0.2%N/A+27.3%$1.31BN/A0.006Positive NewsMFICMidCap Financial Investment2.1253 of 5 stars$13.77-0.4%$14.71+6.9%+3.8%$1.29B$121.29M8.83N/AAnalyst ForecastNMFCNew Mountain Finance2.5703 of 5 stars$11.52-0.8%$11.00-4.5%-10.1%$1.25B$374.84M10.97N/ABCSFBain Capital Specialty Finance1.1326 of 5 stars$16.61-1.2%$17.00+2.3%+9.9%$1.07B$297.79M8.351,000BBDCBarings BDC2.4802 of 5 stars$10.07flat$10.00-0.7%+12.8%$1.06B$289.20M9.3226Positive NewsHQHAbrdn Healthcare InvestorsN/A$17.72+0.5%N/A+15.5%$892.52MN/A0.00147,000CGBDCarlyle Secured Lending2.5237 of 5 stars$16.61+1.1%$16.67+0.3%+12.8%$845.62M$241.63M9.28N/APositive NewsBTOJohn Hancock Financial Opportunities FundN/A$37.72+0.2%N/A+36.2%$743.84MN/A0.002,719Positive NewsPHKPIMCO High Income FundN/A$4.97-0.2%N/A+8.4%$727.72MN/A0.00147,000News CoverageECCEagle Point Credit3.475 of 5 stars$8.98-0.9%$10.00+11.4%-5.5%$690.63M$139.07M11.22N/A Related Companies and Tools Related Companies CET Competitors MFIC Competitors NMFC Competitors BCSF Competitors BBDC Competitors HQH Competitors CGBD Competitors BTO Competitors PHK Competitors ECC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HQL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HQL Stock Alerts